Latest filing published 25 Oct 2022 for AMOEBA, €31k. Read the official filing
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Valerie Filiatre is a declared insider of Amoeba (senior executive), with filings sourced from AMF. The record holds 7 filings, for trades running from 25 February 2021 to 20 October 2022.
No open-market sale appears; the market trades are 4 purchases worth €26k. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 share grants. Since January 2022: 4 purchases and no sales on the market.
The median purchase comes to €3,720. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 3 purchases show a median change of -15.6%, with the price up in 0% of them. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 25 October 2022, reports a share grant of €31k in Amoeba. The last insider purchase was made public on 7 March 2022, 1,685 days ago. Between a trade and the moment it shows up on AMF, the median delay is 5 days. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations